Mark Bieda

Mark Bieda is an Associate Director in Computational Biology and Bioinformatics at Pfizer, having transitioned to this role following the acquisition of Seagen, where they served as a Senior Principal Scientist. With extensive experience in various fields of biomedical science, Mark has led efforts in significant drug development projects, notably contributing to two drugs moving from Phase I to approval. Mark holds a Ph.D. in Neuroscience from Stanford University and an A.B. in Biochemistry from Harvard University. An accomplished researcher, they have published in notable journals and are dedicated to advancing bioinformatics and genomics within educational settings. Mark's collaborative spirit has driven them to work on large NIH projects and across drug development teams.